A carregar...
Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
Endocrine therapies targeting oestrogen signalling have significantly improved breast cancer management. However, their efficacy is limited by intrinsic and acquired resistance to treatment, which remains a major challenge for oestrogen receptor α (ERα)-positive tumours. Though many studies using in...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6600329/ https://ncbi.nlm.nih.gov/pubmed/31195751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20112773 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|